Clinical Endocrinology

Cover image for Clinical Endocrinology

October 1994

Volume 41, Issue 4

Pages 405–541

  1. Commentary

    1. Top of page
    2. Commentary
    3. Case report
    4. Commentary
    5. Rapid communication
    1. The investigation of hypercalcaemia (pages 405–406)

      Ian R. Reid

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02568.x

    1. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations (pages 407–413)

      Janet Walls, Wendy A. Ratcliffe, A. Howell and N. J. Bundred

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02569.x

    2. Familial isolated primary hyperparathyroidism (pages 415–420)

      M. Kassem, X. Zhang, S. Brask, E. F. Erlksen, L. Mosekilde and T. A. Kruse

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02570.x

    3. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism (pages 421–424)

      A. H. Mudde, A. J. H. M. Houben and A. C. Nieuwenhuijzen Kruseman

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02571.x

    4. Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis (pages 425–432)

      Jayne Franklyn, Joan Betteridge, Roger Holder, Jacquie Daykin, John Lilley and Michael Sheppard

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02572.x

    5. Increased insulin sensitivity in patients with aldosterone producing adenoma (pages 433–438)

      Masatoshi Ishimori, Noriyuki Takeda, Syouji Okumura, Toshihiro Murai, Hiroshi Inouye and Keigo Yasuda

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02573.x

    6. Mineralocorticoid and glucocorticoid status in idiopathic haemochromatosis (pages 439–443)

      C. H. Walsh, A. L. Murphy, S. Cunningham and T. J. McKenna

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02574.x

    7. Development and validation of a radioimmunoassay for follistatin in human serum (pages 453–461)

      Christopher P. Gilfillan and David M. Robertson

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02576.x

    8. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome (pages 483–486)

      Euan M. Wallace, Linda M. Harkness, Sheila Burns and William A. Liston

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02579.x

    9. Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocity (pages 487–493)

      J. M. W. Kirk, P. J. Trainer, W. H. Majrowskl, J. Murphy, M. O. Savage and G. M. Besser

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02580.x

    10. The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism (pages 511–516)

      Andrew A. Toogood, Colin G. Beardwell and Stephen M. Shalet

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02583.x

    11. Loss of the normal relationships between growth hormone, growth hormone-binding protein and insulin-like growth factor-I in adolescents with insulin-dependent diabetes mellitus (pages 517–524)

      Kharen L. Clayton, Jeff M. P. Holly, Lena M. S. Carlsson, Jenny Jones, Tim D. Cheetham, Alistair M. Taylor and David B. Dunger

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02584.x

    12. Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer (pages 525–530)

      J. Verhelst, L. Denis, P. Van Vliet, H. Van Poppel, J. Braeckman, P. Van Cangh, J. Mattelaer, O. D'Hulster† and Ch. Mahler

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02585.x

  2. Case report

    1. Top of page
    2. Commentary
    3. Case report
    4. Commentary
    5. Rapid communication
    1. Neonatal primary hyperparathyroidism masked by vitamin D deficiency (pages 531–534)

      K. Meeran, M. Husain, M. Puccini, H. Scott, C. Dionisi-Vici, D. R. Harvey, J. Lynn and R. V. Thakker

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02586.x

    2. Intrapulmonary shunting causing hypoxaemia in a case of carcinoid syndrome (pages 535–537)

      A. Hussain, E. T. Young, J. D. Greaves, P. J. Hammond, J. M. B. Hughes, S. C. Wallis and S. R. Bloom

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02587.x

  3. Commentary

    1. Top of page
    2. Commentary
    3. Case report
    4. Commentary
    5. Rapid communication
    1. Commentary (page 538)

      M. T. Seymour

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02588.x

  4. Rapid communication

    1. Top of page
    2. Commentary
    3. Case report
    4. Commentary
    5. Rapid communication
    1. Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin) (pages 539–541)

      Zvi Laron, Jenny Frenkel, Lrit Gil-Ad, Beatrice Klinger, Ernesto Lubin, Patrick Wuthrich, François Boutignon, Vincent Lengerts and Romano Deghenghi

      Version of Record online: 17 MAR 2008 | DOI: 10.1111/j.1365-2265.1994.tb02589.x

SEARCH

SEARCH BY CITATION